Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS 2022-12-06 17:14
University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health 2022-12-06 14:00
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp 2022-12-05 20:00
The First IBCC Unveiled in Hainan 2022-12-05 15:55
Seoul National University Bundang Hospital Presents Study of SK Biopharmaceuticals' Seizure Detection Wearable Device at AES 2022 2022-12-05 08:00
Telix Announces Executive Leadership Appointments 2022-12-05 06:39
China Pharma Announces Receipt of Noncompliance Notice from NYSE American 2022-12-03 05:10
FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS (FAST) ANNOUNCES $5 MILLION GIFT TO ADVANCE CLINICAL TRIALS IN RARE NEURODEVELOPMENTAL DISORDERS 2022-12-03 01:07
Sirolimus Coated Balloon in BTK Treatment makes a bold presence at VEITH 2022 - Lights up NY Times Square, NASDAQ 2022-12-02 21:10
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies 2022-12-02 18:23
CUVET Successfully Developed the First Stem Cell Transplantation Technology to Treat Pet Diabetes 2022-12-02 10:00
Innoforce Opens GMP Manufacturing Facility & Corporate Headquarters in Hangzhou, China to Provide CDMO Services for Global Supply of RNA, Cell & Gene Therapies 2022-12-02 06:00
BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine 2022-12-01 21:00
MGI Cements Its Presence and Contribution in Singapore's Genomics Landscape at ESMO Asia Congress 2022 2022-12-01 17:10
SK Biopharmaceuticals Names Donghoon Lee, Head of Bio Investment Center of SK Inc., as New CEO 2022-12-01 09:30
NCH ASIA PACIFIC PUTS BACK THE FUN IN CSR ACTIVITIES WITH NCH PLOGGO 2022-12-01 09:00
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio 2022-12-01 08:00
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index 2022-11-30 22:15
TIANGEN to Roll out a Stunning Automated Solution at Cell Bio 2022 2022-11-30 21:20
Ascletis Announces Completion of 180 Patient Enrollment for Phase II Clinical Trial of FASN Inhibitor ASC40 for Acne 2022-11-30 20:39
1 138 139 140 141 142 452